| Literature DB >> 29760680 |
Akhgar Ghassabian1,2,3, Leonardo Trasande1,2,3,4,5.
Abstract
Thyroid hormones are crucial in normal brain development. Transient and mild thyroid hormone insufficiency in pregnancy is also associated with impaired neurodevelopment in the offspring (e.g., 3-4 IQ score loss in association with maternal free thyroxine in the lowest fifth percentile). While inadequate iodine intake remains the most common underlying cause of mild thyroid hormone insufficiency in vulnerable populations including pregnant women, other factors such as exposure to environmental contaminants have recently attracted increasing attention, in particular in interaction with iodine deficiency. Endocrine-disrupting chemicals (EDCs) are natural and synthetic substances with ubiquitous exposure in children and adults including pregnant women. EDCs interfere, temporarily or permanently, with hormonal signaling pathways in the endocrine system by binding to hormone receptors and modifying gene expression. Other mechanisms involve alterations in production, metabolism, and transfer of hormones. Experimental studies have shown that exposures to EDCs affect various brain processes such as neurogenesis, neural differentiation and migration, as well as neural connectivity. Neuroimaging studies confirm brain morphological abnormalities (e.g., cortical thinning) consistent with neurodevelopmental impairments as a result of EDC exposures at standard use levels. In this review, we provide an overview of present findings from toxicological and human studies on the anti-thyroid effect of EDCs with a specific attention to fetal and early childhood exposure. This brief overview highlights the need for additional multidisciplinary studies with a focus on thyroid disruption as an underlying mechanism for developmental neurotoxicity of EDC, which can provide insight into modifiable risk factors of developmental delays in children.Entities:
Keywords: brain; children; endocrine disrupting chemicals; neurodevelopment; thyroid
Year: 2018 PMID: 29760680 PMCID: PMC5936967 DOI: 10.3389/fendo.2018.00204
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Thyroid signaling pathway and endocrine-disrupting chemicals. Groups of chemicals act at: PCB and PCDD: 5, 7; PBDEs: 5, 6, 7, 8; pesticides: 4, 5, 7; PFASs: 5, 6; NIS: 3; BPA: 2, 7; phthalates: 1, 2, 5, 8. Abbreviations: BPA, bisphenol A; NIS, sodium iodide symporters; PBDE, polybrominated diphenyl ethers; PCB, polychlorinated biphenyl; PCDD, polychlorinated dibenzodioxins; PFAS, perfluoroalkyl substances; TRH, thyroid-releasing hormone; TSH, thyroid-stimulating hormone; T4, thyroxine; T3, triiodothyronine. Image of thyroid: by P. J. Witt, AU from the Noun Project, Creative Commons.
Endocrine disrupting chemicals (EDCs) and target of action in the hypothalamus–pituitary–thyroid axis.
| Groups of EDCs | Target of action |
|---|---|
| Polychlorinated biphenyls and polychlorinated dibenzodioxins (PCDD) | Thyroid hormone transportation |
| Polybrominated diphenyl ethers | Thyroid hormone transporters |
| Pesticides | Histology of thyroid gland |
| Perfluoroalkyl substances (PFASs) | Thyroid hormone transportation |
| Sodium iodide symporters (NIS) | Iodine uptake into the thyroid gland |
| Bisphenol A and other phenols | Expression of thyroid receptor genes in the pituitary |
| Phthalates | Thyroid-releasing hormone receptor in the hypothalamus and pituitary |